<DOC>
	<DOCNO>NCT01151020</DOCNO>
	<brief_summary>The Zenith® TX2® Low Profile TAA Endovascular Graft study clinical trial approve US FDA evaluate safety effectiveness Zenith® TX2® Low Profile TAA Endovascular Graft indicate treatment patient aneurysms/ulcers descend thoracic aorta vessel structure suitable repair .</brief_summary>
	<brief_title>TX2® Low Profile TAA Endovascular Graft</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<criteria>Descending thoracic aneurysm diameter ≥ 5.0 cm Descending thoracic aneurysm history growth ≥ 0.5 cm per year Descending thoracic degenerative atherosclerotic ulcer ≥ 10 mm depth 20 mm diameter Less 18 year age Life expectancy le 2 year Pregnant breastfeeding plan become pregnant within 60 month Unwilling comply followup schedule Inability refusal give inform consent Less 30 day beyond primary endpoint investigative drug device study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Aortic Aneurysm</keyword>
	<keyword>Aneurysm</keyword>
	<keyword>Vascular Prosthesis</keyword>
	<keyword>Vascular Disease</keyword>
	<keyword>Blood Vessel Prosthesis Implantation</keyword>
</DOC>